Inquiry
Form loading...
Explore our advanced range of soothing active ingredients designed for modern clinical cosmetics and sensitive skin care.
Ultra-micronized Tranexamic Acid optimized for maximum solubility and rapid skin barrier soothing.
A synergistic blend of bioactive peptides and TXA designed to mitigate post-procedure redness.
Advanced lipid encapsulation technology ensuring deep epidermal penetration and sustained release.
High-potency clinical raw material targeting chronic vascular redness and rosacea-prone skin.
In the rapidly evolving landscape of dermatological science, Tranexamic Acid (TXA) has transcended its traditional medical application as a systemic hemostatic agent to become one of the most sought-after topical ingredients for skin soothing and barrier restoration. Chronic skin sensitivity, persistent redness (erythema), and post-inflammatory responses pose complex challenges for cosmetic formulators. Standard anti-inflammatory agents often provide only temporary relief, whereas Tranexamic Acid addresses the underlying cellular pathways that trigger vascular dilation and epidermal distress.
To understand the profound soothing action of Tranexamic Acid, one must examine the plasminogen-plasmin pathway. When the skin barrier is compromised by ultraviolet (UV) radiation, environmental pollutants, or mechanical micro-trauma (such as microneedling or laser therapies), keratinocytes release plasminogen activators. These activators convert inactive plasminogen in the epidermis into active plasmin.
Plasmin is a serine protease that does not merely degrade fibrin; it triggers a cascade of inflammatory mediators, including arachidonic acid, prostaglandins (specifically PGE2), and leukotrienes. These chemical messengers act directly on the microvasculature of the dermis, causing capillary dilation, which manifests clinically as redness, heat, and swelling. Furthermore, plasmin stimulates the release of basic fibroblast growth factor (bFGF), which promotes angiogenesis and perpetuates chronic redness.
Tranexamic Acid acts as a competitive inhibitor of plasminogen activation. Due to its structural similarity to the amino acid lysine, TXA binds to the lysine-binding sites on the plasminogen molecule, preventing its interaction with keratinocytes. By blocking this initial step, TXA effectively halts the upstream production of inflammatory cytokines and prostaglandins. The result is a stabilized microvascular environment, a significant reduction in visible redness, and a calmer, more resilient skin barrier.
The global market demand for high-purity Tranexamic Acid has experienced exponential growth over the past five years. Valued at over USD 350 million in the cosmetic raw material sector alone, TXA is projected to maintain a compound annual growth rate (CAGR) of 8.2% through 2030. This growth is heavily driven by the "cleanical" beauty trend—where consumers demand clinically proven, non-irritating, and multi-functional ingredients.
Industrially, the synthesis of cosmetic-grade Tranexamic Acid requires stringent purification protocols. While pharmaceutical-grade TXA is widely available, cosmetic formulations demand raw materials with minimal heavy metal content, zero residual solvents, and a purity level exceeding 99.0% as verified by High-Performance Liquid Chromatography (HPLC). Manufacturers must also address formulation challenges: TXA is highly hydrophilic, meaning it dissolves easily in water but struggles to penetrate the lipophilic stratum corneum. To resolve this, advanced B2B suppliers offer micronized powders, liposomal encapsulations, and synergistic complexes that enhance bioavailability without compromising stability.
Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. is strategically located in the historic and technological hub of Xi'an, Shaanxi Province, China. We are a premier, research-driven enterprise specializing in the supply of high-purity peptides, food additives, nutritional supplements, traditional Chinese medicine (TCM) extracts, plant extracts, and natural active ingredients.
By bridging advanced biotechnology with natural resources, we provide the global cosmetics and pharmaceutical industries with clinical-grade raw materials, including our industry-leading Tranexamic Acid, ensuring exceptional stability, safety, and therapeutic efficacy.
Modern clinical aesthetics rely heavily on energy-based devices (lasers, IPL), chemical peels, and mechanical exfoliation (microneedling). While these procedures stimulate long-term collagen synthesis, their immediate aftermath involves controlled epidermal damage, acute erythema, and barrier disruption.
Incorporating 2.0% to 3.0% Tranexamic Acid into post-procedure recovery serums or sheet masks significantly accelerates healing. By suppressing the plasminogen cascade, TXA curtails the inflammatory phase, reducing patient downtime and preventing the onset of Post-Inflammatory Hyperpigmentation (PIH), a common side effect in Fitzpatrick skin types III–VI.
Rosacea is a chronic inflammatory dermatosis characterized by persistent flushing, visible capillaries (telangiectasia), and hypersensitivity. Topical TXA has demonstrated clinical efficacy in reducing the severity of rosacea. It targets the vascular endothelial growth factor (VEGF) pathway, which is typically upregulated in rosacea patients. By downregulating VEGF, TXA limits abnormal capillary proliferation and reduces the hyper-reactivity of the cutaneous microvasculature, providing sustainable soothing relief.
To maximize the soothing properties of Tranexamic Acid, cosmetic chemists frequently pair it with other bioactive compounds:
Our team members are thoroughly familiar with the trade policies and compliance requirements of various countries. We always prioritize customer needs, strictly control quality, and respond efficiently to global market demands.
From order negotiation to after-sales follow-up, dedicated personnel handle the entire process, using professionalism and integrity to build bridges for cross-border cooperation and help partners explore global business opportunities!
Contact Our ExpertsThe company has two major production bases in Weinan and Xianyang. Weinan Shenhekang Bioengineering Co., Ltd., established in 2022, boasts a 6,000-square-meter GMP-compliant production workshop.
Delivering premium active ingredients and customized OEM solutions to cosmetic and pharmaceutical industries worldwide.
Adhering to the corporate philosophy of "rooted in our initial vision, empowered by biotechnology; upholding integrity and taking steady action to benefit the people" and the belief that "quality is our lifeline," the company leverages its group operating model and global distribution network to serve clients in the pharmaceutical, health product, and cosmetics industries.
Our products have gained global recognition and are exported to over 36 countries in Asia, the Middle East, Europe, North America, Latin America, and Africa. With independent import and export licenses, we provide timely and professional services. The company also offers a comprehensive sales and service system, including OEM customization services and tailored solutions for clients with new product ideas but lacking laboratory equipment and human resources.
Explore our diverse raw materials, plant extracts, and custom formulations designed for skin barrier repair and soothing applications.
High-stability active ingredient for professional skin barrier recovery products.
Synergistic botanical extracts that boost the calming effect of topical formulations.
Tailored formulations developed by our in-house R&D team for global brands.
Raw materials manufactured under strict GMP conditions to ensure maximum safety.
Pre-formulated liquid bases optimized for rapid absorption and skin calming.
High-concentration actives targeting chronic redness and vascular dilation.
Lipid-replenishing compounds that work in tandem with Tranexamic Acid.
Advanced cosmetic peptides designed to soothe and restore compromised skin.